Abstract
The objective of this study is to develop an oral formulation of famotidine niosomes coated with a mucoadhesive polymer, chitosan. Famotidine (FMT) has low oral bioavailability of 40–45% and short half-life between 2.5 to 4 h. Famotidine is classified as class IV in BCS because of its low aqueous solubility (0.1% w/v) and low permeability. Thus, FMT was loaded to the bioadhesive coated niosomes to improve its solubility, enhance its oral bioavailability, and sustain FMT release pattern. Different formulations were prepared by thin-film hydration method and characterized in terms of entrapment efficiency, morphological features, vesicle size, and zeta potential. In vitro release and ex vivo permeability of famotidine from the formulations were evaluated. The optimized formula was coated with chitosan and its mucoadhesion and stability in bile salt was tested. The optimized formula showed a high entrapment efficiency of 74%, as well sustained the in vitro release of FMT in the simulated gastric medium and enhanced its permeation through an excised goat’s intestinal membrane by 1.4 fold in comparison to FMT control suspension. The mucoadhesive coated formula exhibited a significantly higher (p < 0.05) mucoadhesive efficiency and more stability in the bile salt as compared to the uncoated formula. Therefore, it could be considered as an efficient delivery system to maintain the prolonged release of FMT and improve its oral bioavailability.
Similar content being viewed by others
REFERENCES
Saraf S, Kaur CD, Rathi R, Saraf S. Colloidosomes an advanced vesicular system in drug delivery. Asian J Sci Res. 2011;4(1):1–15.
Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems—an overview. Adv Colloid Interf Sci. 2012;183–184:46–54. doi:10.1016/j.cis.2012.08.002.
Srinivas S, Kumar YA, Hemanth A, Anitha M. Preparation and evaluation of niosomes containing aceclofenac. Dig J Nanomater Bios. 2010;5(1):249–54.
Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 2013;20(3–4):120–6. doi:10.3109/10717544.2013.779332.
Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1(4):208–19.
Rani NP, Suriyaprakash TNK, Senthamarai R. Formulation and evaluation of rifampicin and gatifloxacin niosomes on logarithmic-phase cultures of mycobacterium tuberculosis. Int J Pharm Biol Sci. 2010;1:379–87.
Mizrahy S, Raz SR, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K, et al. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J Control Release. 2011;156(2):231–8. doi:10.1016/j.jconrel.2011.06.031.
Zubairu Y, Negi LM, Iqbal Z, Talegaonkar S. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations. Asian J Pharm Sci. 2015;10(4):322–30.
M.J. O’Neil, A. Smith, P.E. Heckelman, J.R. Obenchain, J.R. Gallipeau, M.A. D’Arecca, S. Budavari, The Merck index. 13th ed., Merk and co. Inc., NJ, 2001, p. 696 In.
Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;69(3):993–1003. doi:10.1016/j.ejpb.2008.02.017.
Hassan MA, Suleiman MS, Najib NM. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin. Int J Pharm. 1990;58(1):19–24.
Matsuda H, Matsumoto S, Kaguragi K, Kurihara K, Tochigi K, Tomono K. Determination and correlation of solubilities of famotidine in water + co-solvent mixed solvents. Fluid Phase Equilib. 2011;302(1–2):115–22.
Raval JA, Patel MM. Formulation and characterization of gastroretentive discs containing famotidine. Braz Arch Biol Technol. 2011;54(2):293–300.
Jha SK, Karki R, Puttegowda VD, Harinarayana D. In vitro intestinal permeability studies and pharmacokinetic evaluation of famotidine microemulsion for oral delivery. Int Sch Res Not. 2014;2014:e452051. doi:10.1155/2014/452051.
Patel RP, Baria AH, Pandya NB. Stomach-specific drug delivery of famotidine using floating alginate beads. Int J Pharmatech Res. 2009;1(2):288–91.
Gupta R, Prajapati SK, Pattnaik S, Bhardwaj P. Formulation and evaluation of novel stomach specific floating microspheres bearing famotidine for treatment of gastric ulcer and their radiographic study. Asian Pac J Trop Biomed. 2014;4(9):729–35.
Patel DJ, Patel JK. Design and evaluation of famotidine mucoadhesive nanoparticles for aspirin induced ulcer treatment. Braz Arch Biol Technol. 2013;56(2):223–36.
Deb P, Dash S, Murthy PN. Development and statistical optimization of mucoadhesive drug delivery system of famotidine using Hibiscus esculentus polysaccharide. Int J Drug Deliv. 2014;6(3):311–25.
Jain CP, Vyas SP. Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul. 1995;12(4):401–7. doi:10.3109/02652049509087252.
Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290(1–2):155–9. doi:10.1016/j.ijpharm.2004.10.026.
Yang T, Choi M-K, Cui F-D, Kim JS, Chung S-J, Shim C-K, et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release. 2007;120(3):169–77. doi:10.1016/j.jconrel.2007.05.011.
Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–9.
Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23(10):1160–8.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983 May 1;15(1):25–35.
Ali MS, Alam MS, Alam N, Siddiqui MR. Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran J Pharm Res IJPR. 2014;13(4):1125–40.
Filipović-Grčić J, Škalko-Basnet N, Jalšienjak I. Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencapsul. 2001;18(1):3–12. doi:10.1080/026520401750038557.
Pawar H, Douroumis D, Boateng JS. Preparation and optimization of PMAA–chitosan–PEG nanoparticles for oral drug delivery. Colloids Surf B Biointerfaces. 2012;90:102–8. doi:10.1016/j.colsurfb.2011.10.005.
Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10(4):251–62.
Ai X, Zhong L, Niu H, He Z. Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles. Asian J Pharm Sci. 2014;9(5):244–50.
Palei NN, Das MK. Sorbitan ester niosomes for topical delivery of rofecoxib. http://nopr.niscair.res.in/handle/123456789/11742 [Internet]. 2011 Jun [cited 2016 Jan 1]; Available from: http://imsear.hellis.org/handle/123456789/145147
Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci Publ Can Soc Pharm Sci Société Can Sci Pharm. 2002 Dec;5(3):220–5.
Hao Y, Zhao F, Li N, Yang Y, Li K ‘An. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002;244(1–2):73–80.
Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010;99(4):2049–60. doi:10.1002/jps.21944.
Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm. 2000;26(2):217–22. doi:10.1081/DDC-100100348.
O’Brien RW, Midmore BR, Lamb A, Hunter RJ. Electroacoustic studies of moderately concentrated colloidal suspensions. Faraday Discuss Chem Soc. 1990;90:301–12. doi:10.1039/DC9909000301.
Girigoswami A, Das S, De S. Fluorescence and dynamic light scattering studies of niosomes-membrane mimetic systems. Spectrochim Acta A Mol Biomol Spectrosc. 2006;64(4):859–66. doi:10.1016/j.saa.2005.08.015/j.saa.2005.08.015.
Mohamed A, Bendas ER, Mohamed S, Abdel-Jaleel GA, Nasr-Alla SM. Formulation and evaluation of topical niosomal gel of baclofen. J Chem Pharm Res. 2015;7(1):277–88.
Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11(3):1119–27. doi:10.1208/s12249-010-9480-2.
Mehta SK, Jindal N, Kaur G. Quantitative investigation, stability and in vitro release studies of anti-TB drugs in triton niosomes. Colloids Surf B Biointerfaces. 2011;87(1):173–9. doi:10.1016/j.colsurfb.2011.05.018.
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.
Mokale VJ, Patil HI, Patil AP, Shirude PR, Naik JB. Formulation and optimisation of famotidine proniosomes: an in vitro and ex vivo study. J Exp Nanosci. 2016;11(2):97–110.
Jung I-W, Han H-K. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization. Int J Nanomedicine. 2014;9:2299–306. doi:10.2147/IJN.S61181.
Naderkhani E, Erber A, Škalko-Basnet N, Flaten GE. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay. J Pharm Sci. 2014;103(2):661–8.
Jain NK, Chaurasia M, Jain SK. Investigation of galactosylated low molecular weight chitosan-coated liposomes for cancer specific drug delivery. Trop J Pharm Res. 2014;13(5):661–8.
Sogias IA, Williams AC, Khutoryanskiy VV. Why is chitosan mucoadhesive? Biomacromolecules. 2008;9(7):1837–42. doi:10.1021/bm800276d.
Rowland RN, Woodley JF. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim Biophys Acta BBA - Lipids Lipid Metab. 1980;620(3):400–9.
Acknowledgements
The authors would like to thank the Dubai Pharmacy College, for providing the necessary facilities for carrying out this investigation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Khalifa, AZ.M., Abdul Rasool, B.K. Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine. AAPS PharmSciTech 18, 3064–3075 (2017). https://doi.org/10.1208/s12249-017-0780-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-017-0780-7